Severe adverse skin reaction and desensitization to sorafenib

Ann Allergy Asthma Immunol. 2016 Aug;117(2):209-10. doi: 10.1016/j.anai.2016.06.013. Epub 2016 Jun 30.

Authors

Kotryna Linauskiene¹, Laura Malinauskiene², Edvina Vitkauskaite³, Anzelika Chomiciene², Audra Blaziene²

Affiliations

¹ Center of Pulmonology and Allergology, Vilnius University, Vilnius, Lithuania. Electronic address: Kotryna.linauskiene@santa.lt.
² Center of Pulmonology and Allergology, Vilnius University, Vilnius, Lithuania.
³ Hematology, Oncology and Transfusion Medicine Center, Vilnius University, Vilnius, Lithuania.

PMID: 27372655
DOI: 10.1016/j.anai.2016.06.013

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Carcinoma, Hepatocellular / complications
Carcinoma, Hepatocellular / drug therapy*
Cell Growth Processes / drug effects
Desensitization, Immunologic / methods*
Drug Hypersensitivity / immunology
Drug Hypersensitivity / therapy*
Female
Humans
Immune Tolerance
Liver Neoplasms / complications
Liver Neoplasms / drug therapy*
Niacinamide / adverse effects
Niacinamide / analogs & derivatives*
Niacinamide / therapeutic use
Phenylurea Compounds / adverse effects
Phenylurea Compounds / therapeutic use*
Sorafenib
Urticaria
Young Adult

Substances

Antineoplastic Agents
Phenylurea Compounds
Niacinamide
Sorafenib